AR and salivary duct carcinoma: Moreover, studies on salivary duct carcinoma show that treatment with DHT increases cell proliferation, migration, and invasion, while the AR inhibitor, fluorouracil, blocks the effects of DHT, suggesting that the androgen-AR signaling axis exerts effects on cellular proliferation, migration, and invasiveness 38.